Prospective Randomized Study on the Efficacy of Blue Light in the Treatment of Psoriasis Vulgaris

Publisher： Karger

E-ISSN： 1421-9832|223|3|251-259

ISSN： 1018-8665

Source： Dermatology, Vol.223, Iss.3, 2011-11, pp. : 251-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospective Randomized Long-Term Study on the Efficacy and Safety of UV-Free Blue Light for Treating Mild Psoriasis Vulgaris

By  

Dermatology, Vol. 231, Iss. 1, 2015-06 ,pp. : 24-34

Karger

Access to resources Recommend Favorite

Prospective, Randomized Study on the Efficacy and Safety of Local UV-Free Blue Light Treatment of Eczema

By  

Dermatology, Vol. 232, Iss. 4, 2016-08 ,pp. : 496-502

Karger

Access to resources Recommend Favorite

Effectiveness of Inpatient Treatment on Quality of Life and Clinical Disease Severity in Atopic Dermatitis and Psoriasis Vulgaris – A Prospective Study

By  

Dermatology, Vol. 214, Iss. 1, 2006-12 ,pp. : 68-76

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Clinical Use of Etanercept for the Treatment of Moderate-to-Severe Psoriasis in Spain: Results of a Multicentric Prospective Study at 12 Months Follow-Up

By  

Dermatology, Vol. 225, Iss. 3, 2012-12 ,pp. : 220-230

Karger

Access to resources Recommend Favorite

Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis Vulgaris

By  

Dermatology, Vol. 213, Iss. 4, 2006-12 ,pp. : 319-326

Karger

Access to resources Recommend Favorite